We found 27% K-Ras mutations in the whole series and a statistical association with M+ tumours (univariate analysis P=0.016; multivariate analysis P=0.019), suggesting K-Ras activation as an important determinant of extracolic tumour spread. The gene discussed is KRAS; the disease is neoplasm.